Abstract:Background: Neuronal ceroid lipofuscinoses, (NCLs or Batten disease) are a group of inherited, early onset, fatal neurodegenerative diseases associated with mutations in 13 genes. All forms of the disease are characterized by lysosomal accumulation of fluorescent storage material, as well as profound neurodegeneration, but the relationship of the various genes' function to a single biological process is not obvious. In this study, we used a well-characterized mouse model of classical late infantile NCL (cLINCL) in which the tripeptidyl peptidase 1 (Tpp1) gene is disrupted by gene targeting, resulting in loss of detectable TPP1 activity and leading to progressive neurological phenotypes including ataxia, increased motor deficiency, and early death. Methods: In order to identify genes and pathways that may contribute to progression of the neurodegenerative process, we analyzed forebrain/midbrain and cerebellar transcriptional differences at 1, 2, 3 and 4 months of age in control and TPP1-deficient mice by global RNA-sequencing. Results: Progressive neurodegenerative inflammatory responses involving microglia, astrocytes and endothelial cells were observed, accompanied by activation of leukocyte extravasation signals and upregulation of nitric oxide production and reactive oxygen species. Several astrocytic (i.e., Gfap, C4b, Osmr, Serpina3n) and microglial (i.e., Ctss, Itgb2, Itgax, Lyz2) genes were identified as strong markers for assessing disease progression as they showed increased levels of expression in vivo over time. Furthermore, transient increased expression of choroid plexus genes was observed at 2 months in the lateral and fourth ventricle, highlighting an early role for the choroid plexus and cerebrospinal fluid in the disease pathology. Based on these gene expression changes, we concluded that neuroinflammation starts, for the most part, after 2 months in the Tpp1-/- brain and that activation of microglia and astrocytes occur more rapidly in cerebellum than in the rest of the brain; confirming increased severity of inflammation in this region. Conclusions: These findings have led to a better understanding of cLINCL pathological onset and progression, which may aid in development of future therapeutic treatments for this disease.

Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation

Loss of the lysosomal protein CLN3 modifies the lipid content of the nuclear envelope leading to DNA damage and activation of YAP1 pro-apoptotic signaling

The Batten disease protein CLN3 is important for stress granules dynamics and translational activity

Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease.

CLN3 is required for the clearance of glycerophosphodiesters from lysosomes

Loss of CLN3 in microglia leads to impaired lipid metabolism and myelin turnover

CLN3 deficiency leads to neurological and metabolic perturbations during early development

The Batten Disease Gene CLN3 Confers Resistance to Endoplasmic Reticulum Stress Induced by Tunicamycin.

Disruption of lysosomal nutrient sensing scaffold contributes to pathogenesis of a fatal neurodegenerative lysosomal storage disease

Glycerophosphodiesters inhibit lysosomal phospholipid catabolism in Batten disease

Genetic and cellular basis of impaired phagocytosis and photoreceptor degeneration in CLN3 disease.

Membrane topology of CLN3, the protein underlying Batten disease.

Mutations in CLCN6 as a Novel Genetic Cause of Neuronal Ceroid Lipofuscinosis

Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression

[Genetic Study of a Family of Neuronal Ceroid Lipofuscinosis Caused by a Heterozygous Mutation of CLN6 Gene].

KCTD7 Mutations Impair the Trafficking of Lysosomal Enzymes Through CLN5 Accumulation to Cause Neuronal Ceroid Lipofuscinoses

Autophagy–lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease

Proteomic Profiling in the Brain of CLN1 Disease Model Reveals Affected Functional Modules

Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A

CLN7 is an organellar chloride channel regulating lysosomal function

Biallelic loss-of-function variants of SLC12A9 cause lysosome dysfunction and a syndromic neurodevelopmental disorder